Correction: HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes

Correction: HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3667198/?tool=EBI

Similar Items

Correction: HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes.
by: Quentin Lepiller, et al.
Published: (2013-01-01)

Differential Inhibite Effect of Xanthohumol on HepG2 Cells and Primary Hepatocytes
by: Xiuli Zhang, et al.
Published: (2022-11-01)

Naringenin Induces HepG2 Cell Apoptosis via ROS-Mediated JAK-2/STAT-3 Signaling Pathways
by: Ming Zhang, et al.
Published: (2023-06-01)

Lipid-Independent Regulation of PLIN5 via IL-6 through the JAK/STAT3 Axis in Hep3B Cells
by: Marinela Krizanac, et al.
Published: (2023-04-01)

Gypenoside XIII regulates lipid metabolism in HepG2 hepatocytes and ameliorates nonalcoholic steatohepatitis in mice
by: Shu‐Chen Cheng, et al.
Published: (2024-03-01)

Comparison of the effect of betanin on STAT3, STAT5, and KAP1 proteins in HepG2 and THLE-2 cells
by: Hanna Szaefer, et al.
Published: (2023-06-01)

Effect of Quercetin on ABCC6 Transporter: Implication in HepG2 Migration
by: Vittorio Abruzzese, et al.
Published: (2021-04-01)

Cytotoxic Effect of Girinimbine on HepG2 Cells
by: Mohan, Suvita Syam
Published: (2011)

Hepatocyte Growth Factor Enhances Antineoplastic Effect of 5-Fluorouracil by Increasing UPP1 Expression in HepG2 Cells
by: Manabu Okumura, et al.
Published: (2022-08-01)

Combination Treatment of Deep Sea Water and Fucoidan Attenuates High Glucose-Induced Insulin-Resistance in HepG2 Hepatocytes
by: Shan He, et al.
Published: (2018-02-01)

DNMT1/PKR double knockdowned HepG2 (HepG2-DP) cells have high hepatic function and differentiation ability
by: Rieko Tanaka-yachi, et al.
Published: (2022-12-01)

The Expectation and Reality of the HepG2 Core Metabolic Profile
by: Olga I. Kiseleva, et al.
Published: (2023-08-01)

Anticarcinogenic Efficacy of Fucoxanthin on HepG2 Cell Lines
by: P Sangavi, et al.
Published: (2022-02-01)

Astragalus polysaccharide ameliorates insulin resistance in HepG2 cells through activating the STAT5/IGF‐1 pathway
by: Xinxin Yue, et al.
Published: (2023-11-01)

The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
by: Chandra Sekhar Amara, et al.
Published: (2024-02-01)

Antiproliferative, antioxidant and apoptosis effects of Zingiber Officenale and 6-Gingerol on HepG2 cells
by: Harliansyah, Harliansyah, et al.
Published: (2009)

Extracellular ATP Regulates CD73 and ABCC6 Expression in HepG2 Cells
by: Fabio Martinelli, et al.
Published: (2018-08-01)

Bridging Radiotherapy to Immunotherapy: The IFN–JAK–STAT Axis
by: Lewis Zhichang Shi, et al.
Published: (2021-11-01)

Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia
by: Ylenia Marino, et al.
Published: (2023-03-01)

The role of IL‐6/JAK/STAT signal in female infertility caused by hydrosalpinx
by: Jia Deng, et al.
Published: (2023-06-01)

The role of IL-6/JAK2/STAT3 signaling pathway in cancers
by: Bei Huang, et al.
Published: (2022-12-01)

Selective cytotoxicity of goniothalamin against hepatoblastoma HepG2 cells.
by: Al-Qubaisi, Mothanna, et al.
Published: (2011)

Effects of diisononyl phthalate on lipid metabolism in HepG2 cells
by: Xinjing WANG, et al.
Published: (2024-01-01)

FTIR Microspectroscopy for the Assessment of Mycoplasmas in HepG2 Cell Culture
by: Piman Pocasap, et al.
Published: (2020-05-01)

Effects of Erythrodiol on the Antioxidant Response and Proteome of HepG2 Cells
by: Juan Luis Peñas-Fuentes, et al.
Published: (2021-12-01)

Cell Dome as an Evaluation Platform for Organized HepG2 Cells
by: Ryotaro Kazama, et al.
Published: (2022-12-01)

Effects of dehydroabietic acid on nontarget lipidomics and proteomics of HepG2
by: Zhikai Xiahou, et al.
Published: (2022-12-01)

NOX1 supports the metabolic remodeling of HepG2 cells.
by: Katharina Bertram, et al.
Published: (2015-01-01)

Selective Cytotoxicity of Goniothalamin against Hepatoblastoma HepG2 Cells
by: Noorjahan B. Alitheen, et al.
Published: (2011-04-01)

Research progress on IL-6/JAK/STAT3 in the development and treatment of prostate cancer
by: CHEN Hao, CHEN Tao, WU Jing
Published: (2022-01-01)

Suppression effect of eurycomanone on the growth of HepG2 tumour transplanted in mice
by: Zakaria, Yusmazura
Published: (2011)

Gamma-tocotrienol alters protein expression of HepG2 cell line
by: Farahani ARS,, et al.
Published: (2008)

Zerumbone Exerts Antiproliferative Activity via Apoptosis on HepG2 Cells
by: Syed Alwi, Sharifah Sakinah, et al.
Published: (2007)

The effect of polystyrene nanoplastics on arsenic-induced apoptosis in HepG2 cells
by: Lei He, et al.
Published: (2024-01-01)

In Vitro Toxicity Screening of Fifty Complex Mixtures in HepG2 Cells
by: Sunmi Kim, et al.
Published: (2024-02-01)

Stressful Effects of T-2 Metabolites and Defense Capability of HepG2 Cells
by: Mercedes Taroncher, et al.
Published: (2022-12-01)

Behavioral Changes in Stem-Cell Potency by HepG2-Exhausted Medium
by: Francesca Balzano, et al.
Published: (2020-08-01)

GPR21 Inhibition Increases Glucose-Uptake in HepG2 Cells
by: Gemma K. Kinsella, et al.
Published: (2021-10-01)

Exploring Dynamic Metabolome of the HepG2 Cell Line: Rise and Fall
by: Olga I. Kiseleva, et al.
Published: (2022-11-01)

The Curious Case of the HepG2 Cell Line: 40 Years of Expertise
by: Viktoriia A. Arzumanian, et al.
Published: (2021-12-01)